Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea)

Wang, Dong D., Toledo, Estefanía, Hruby, Adela, Rosner, Bernard A., Willett, Walter C., Sun, Qi, Razquin, Cristina, Zheng, Yan +17 more·2017·Circulation
DOI 10.1161/circulationaha.116.024261

Cited by (327)

Items 301–327 of 327

  1. Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy
    Ruth Magaye, David M. Kaye, Bing Hui Wang · 2025 · International Journal of Molecular Sciences
  2. Additional file 1 of Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
    Damien Denimal, Sarah Béland‐Bonenfant, Jean-Paul Paı̈s de Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno L Vergès, Jean‐Michel Petit · 2023 · Figshare
  3. Additional file 2 of Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
    Damien Denimal, Sarah Béland‐Bonenfant, Jean-Paul Paı̈s de Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno L Vergès, Jean‐Michel Petit · 2024 · Figshare
  4. Additional file 5 of Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
    Damien Denimal, Sarah Béland‐Bonenfant, Jean-Paul Paı̈s de Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno L Vergès, Jean‐Michel Petit · 2024 · Figshare
  5. Additional file 4 of Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
    Damien Denimal, Sarah Béland‐Bonenfant, Jean-Paul Paı̈s de Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno L Vergès, Jean‐Michel Petit · 2024 · Figshare
  6. Additional file 3 of Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
    Damien Denimal, Sarah Béland‐Bonenfant, Jean-Paul Paı̈s de Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno L Vergès, Jean‐Michel Petit · 2024 · Figshare
  7. Additional file 1 of Association between ceramides and coronary artery stenosis in patients with coronary artery disease
    Tu, Chenchen, Lan Xie, Wang, Zhenjie, Zhang, Lili, Wu, Hongmei, Ni, Wei, Li, Caixia, Li, Lin, Zeng, Yong · 2020 · Figshare
  8. In Vitro Modeling of Age‐Associated Lipid Mediator's Impact on Vascular Biology Following Platelet Concentrate Transfusion
    Amélie Prier, Mailys Portier, Chloe Heranney, Nancy Kouadio, Charles‐Antoine Arthaud, Marie‐Ange Eyraud, Marco Heestermans, Justine Bertrand‐Michel, Hind Hamzeh‐Cognasse, Fabrice Cognasse et al. · 2026 · Aging Cell
  9. Lipoprotéines riches en triglycérides chez le patient diabétique de type 2 : Effets sur l'activation plaquettaire et profil sphingolipidomique
    Marie Michèle Boulet · 2020
  10. Dietary patterns drive sphingolipid metabolic rewiring: Integrative insights from transcriptomics and sphingolipidomics
    Shuo Yang, Nan Meng, Xincen Wang, Yanjun Liu, Peixu Cong, Changhu Xue, Jie Xu · 2026 · Food Bioscience
  11. Subtype‐Specific Causal Effects of C16 and C24 Ceramides on Heart Failure: Evidence From Univariable and Multivariable Mendelian Randomization Analyses
    Zeda Wang, Yakui Xue, Kaishan Han · 2026 · Lipids
  12. Intérêt du machine learning dans la recherche de marqueurs impliqués dans le remodelage cardiaque et le syndrome neuro-cardiaque
    Xavier Dieu · 2022 · theses.fr (ABES)
  13. Ceramides and Type 2 Diabetes: A Scoping Review of Mechanisms, Insulin Resistance, and Nutritional Interventions
    Karin Collins, Jyotsna Chawla, Priya Krishnakumar · 2026 · Cureus
  14. Temporal changes in circulating metabolites after metabolic and bariatric surgery and risk of incident coronary heart disease: evidence from prospective cohort and nested case–control studies
    Yulu Zheng, Zicheng Wang, Lei Wang, Charles Robb Flynn, Xiao‐Ou Shu, Wayne J. English, Jason M. Samuels, You Chen, Loren Lipworth, Deepak Gupta et al. · 2026 · International Journal of Surgery
  15. Molecular Signature of Prediabetes With High‐Risk of Diabetes Revealed by Deep Plasma Proteome
    Yuanyuan Yin, Xia Gao, Qingrun Li, Ling Lu, Haoqiang Zhang, Qingqing Wu, Jincheng Shi, Conghui Liu, Ling Yue, Shifu Xiao et al. · 2026 · Diabetes Obesity and Metabolism
  16. Longitudinal lipidomic markers of cardiac aging and risk of coronary heart disease in American Indians: the Strong Heart Family Study
    Mingjing Chen, Yixi Sun, Guanhong Miao, Xiaoxiao Wen, Alexander C. Razavi, Camilo Fernandez, Mary J. Roman, Richard B. Devereux, Richard R. Fabsitz, Ying Zhang et al. · 2026 · GeroScience
  17. Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights
    Hassan Darvakh · 2026 · Jundishapur Journal of Natural Pharmaceutical Products
  18. Metabolic regulation and diabetic cardiomyopathy
    Hengzhi Du, Chen Chen · 2026 · Elsevier eBooks
  19. Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress
    Fátima Cardoso, Eduardo Costa-Camilo, Isabel Duarte, Graça P. Carvalho, Rita Gonçalves Sobral, João M. G. C. F. Almeida, Carla Pinheiro · 2026 · Frontiers in Nutrition
  20. Concurrent training is associated with enhanced post-exercise ceramide clearance and fat oxidation capacity in individuals with type 2 diabetes following lifestyle intervention
    Mikael Flockhart, Michael Svensson, Emad Ehtesham, Mats Ryberg, Andreas Stomby, Torbjörn Åkerfeldt, Julia Otten, Tommy Olsson, Elin Chorell · 2026 · Diabetologia
  21. The effect of sumac and cinnamon on lipid profile and quality of life in patients with acute myocardial infarction, type 2 diabetes, and overweight/obesity: study protocol for a randomized double-blind controlled trial
    Ashkan Golmohammadi, Amir Peikar, Farzad Karımpour, Fatemeh Zadeh Bagheri, Seyed Bahman Panahande · 2026 · Cardiovascular Diabetology – Endocrinology Reports
  22. Preoperative Cer(d18:1/24:0) Shows Promise as a Candidate Predictor of Plasma Lipid Phenotypes Following Roux‐en‐Y Gastric Bypass in Women: An Exploratory Analysis of the SURMetaGIT Study
    Gabriela Lemos, Raquel Susana Torrinhas, Jessica Monteiro Volejnik Pino, Philip C. Calder, Steven B. Heymsfield, Natasha Mendonça Machado, Dan Linetzky Waitzberg · 2026 · Journal of Obesity
  23. Olea europaea L. (Zaitūn): A review on chief bioactive phytoconstituents, pharmacological & clinical evidence
    Sadia Nikhat, Mohammad Fazil · 2026 · Food and Humanity
  24. Sphingolipid Metabolism in Obesity: Bidirectional Regulation and Comparative Perspectives on Plant Sphingolipids
    Mingrui Li, Yunlong Yao, Tianxing Li, Tianqi Cai, Fufangyu Zhao, Yini Fang, Yi Zheng, Chenyu Fei, Can Yang, Wenlong Sun et al. · 2026 · Nutrients
  25. Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial
    Angelika Witoslawska, Christine Dawczynski, Mitja Lääperi, Reini Hurme, Michael Kiehntopf, Stefan Lorkowski A, Winfried März, Reijo Laaksonen, Angela P. Moissl · 2026 · Journal of clinical lipidology
  26. Sphingolipid–renal interplay in coronary artery calcification: ceramide profiling and imaging validation from the CRUISE-MET study
    Qiang Chen, Sijia Guo, Xuexi Li, Yike Li, Yingying Xie, Sunjing Fu, Ruoyun Ma, Xiaxia Peng, Sheng Xie, Yanxiang Gao et al. · 2026 · Frontiers in Endocrinology
  27. Ceramides as Biomarkers of Risk Prediction and Prognosis in Cardiovascular and Other Diseases: Are We There Yet?
    Thansi Garikipati, Priya Dubey, Dylan Work, Sanidhya Oli, Dhruv Akhilesh Sharma, Subroto B. Chatterjee · 2026 · International Journal of Molecular Sciences